BioCurate
BioCurate is a collaborative venture dedicated to translating Australian medical research into high-quality preclinical candidates for the bio-pharmaceutical industry. Jointly formed by the University of Melbourne and Monash University with support from the Victorian State Government, BioCurate bridges the gap between academia and industry to accelerate the development of new therapies. The team of global biomedical experts brings hands-on industry experience and a proven track record to foster innovation, collaboration, and commercialization in the biotech sector.
Industries
Nr. of Employees
small (1-50)
BioCurate
Victoria, Blaenau Gwent, United Kingdom, Europe
Products
Portfolio of preclinical and proof-of-concept projects
A managed portfolio comprising portfolio-stage and proof-of-concept projects across therapeutic areas such as oncology and neurological disease.
Portfolio of preclinical and proof-of-concept projects
A managed portfolio comprising portfolio-stage and proof-of-concept projects across therapeutic areas such as oncology and neurological disease.
Services
Provide targeted POC funding to early-stage academic projects to generate additional validation data and address identified development gaps.
Deliver a structured assessment workflow (initial screening/BOA, EOI, Tier 1–3 reviews) with internal and external expert input to evaluate scientific, clinical and commercial potential.
Support sourcing and engaging industry partners, structuring exclusive evaluation and license agreements and advising on pathways to commercial deals.
Develop plans for IND-ready preclinical packages and advise on experimental programs required to support regulatory submissions and clinical entry.
Provide advisory support on intellectual property, lifecycle management, regulatory strategy and medical affairs to inform development and commercial decisions.
Provide targeted POC funding to early-stage academic projects to generate additional validation data and address identified development gaps.
Deliver a structured assessment workflow (initial screening/BOA, EOI, Tier 1–3 reviews) with internal and external expert input to evaluate scientific, clinical and commercial potential.
Support sourcing and engaging industry partners, structuring exclusive evaluation and license agreements and advising on pathways to commercial deals.
Develop plans for IND-ready preclinical packages and advise on experimental programs required to support regulatory submissions and clinical entry.
Provide advisory support on intellectual property, lifecycle management, regulatory strategy and medical affairs to inform development and commercial decisions.
Expertise Areas
- Translational research and preclinical development
- Drug discovery (small molecules, antibodies, PROTACs, microbiome therapeutics)
- Project evaluation and portfolio management
- Commercialisation and licensing strategy
Key Technologies
- Medicinal chemistry
- Antibody therapeutics
- PROTAC development
- Microbiome-based therapeutics